The right treatment for the right patient at the right time. That’s the future of cancer care. #TCSC
0
0
0
0
Hashtag
#TCSC
Advertisement · 728 × 90
A newly approved PD-L1 test is helping guide Keytruda use in esophageal and GEJ cancers, matching patients with treatments more precisely than ever before.
#PrecisionMedicine #CancerTreatment #TCSC
www.curetoday.com/view/fda-app...
0
0
1
0
Hope should always be grounded in science. Patients deserve treatments that are proven to work. #TCSC
0
0
0
0
Not every “alternative” cancer treatment is backed by science. Experts are urging caution around antiparasitic drugs being promoted without clinical evidence. Evidence still matters.
#CancerAwareness #EvidenceBased #TCSC
www.pharmacytimes.com/view/from-fa...
0
0
1
0
Progress isn’t just about stronger treatments. It’s about making them safer and more tolerable for patients. #TCSC
0
0
0
0
Immunotherapy is transforming cancer care, but managing side effects is just as critical as the breakthrough itself. Smarter care means better outcomes and safer treatment journeys.
#Immunotherapy #CancerCare #TCSC
www.curetoday.com/view/balanci...
0
0
1
0
Stories like this remind us what progress really looks like. Behind every breakthrough is a life changed. #Survivorship #TCSC
0
0
0
0
A powerful survival story: thriving after a rectal cancer diagnosis. With the right treatment and resilience, patients are not just surviving, they’re rebuilding their lives. #CancerSurvivor #Hope #TCSC
www.michiganmedicine.org/health-lab/t...
0
0
1
0
When time matters, speed and accuracy save lives. AI is starting to deliver both. #TCSC
0
0
0
0
AI is now helping guide cancer treatment decisions in real time. A new lab-on-a-chip platform could allow same-day therapy choices for pediatric patients. Faster decisions, better outcomes.
#AIinHealthcare #PrecisionMedicine #TCSC
attheu.utah.edu/facultystaff...
0
0
1
0
Minimising damage while maximising impact is where modern cancer treatment is heading. This is a solid step in that direction. #TCSC
0
0
0
0
New results from a kidney cancer trial show cryoablation technology delivering promising outcomes for small tumours. Less invasive, more targeted, and increasingly effective.
#KidneyCancer #CancerInnovation #TCSC
www.targetedonc.com/view/cryoabl...
0
0
1
0
Survival is the goal. Living well afterwards is the mission. Research like this is finally treating both as equally important. #TCSC
0
0
0
0
Life after cancer treatment matters just as much as survival. The BRIGHT trial is focusing on improving quality of life for head and neck cancer patients, where recovery can be especially challenging.
#CancerSurvivorship #QualityOfLife #TCSC
web.musc.edu/about/news-c...
1
0
1
0
Cancer treatment is no longer one-size-fits-all. The more personalised it becomes, the better the results. #TCSC
0
0
0
0
A major step forward in precision care: adaptive radiation therapy is now being offered, tailoring treatment in real time to improve outcomes and reduce unnecessary exposure. This is how treatment gets smarter.
#RadiationTherapy #CancerCare #TCSC
www.roswellpark.org/newsroom/202...
0
0
1
0
Step by step, treatment is becoming smarter, more targeted, and more effective. That’s how progress actually looks. #TCSC
0
0
0
0
Blood cancer care is evolving fast. New advances in treating multiple myeloma are changing what was once considered a very difficult disease into something far more manageable. Real hope, backed by science.
#BloodCancer #Myeloma #TCSC
news.llu.edu/health-welln...
0
0
1
0
Behind every statistic is someone who refused to give up. Survival stories are becoming more common thanks to research, early detection, and better treatments. Let’s keep pushing forward. #TCSC
0
0
0
0
Cancer survival is reaching record highs, with 7 in 10 people now living 5+ years after diagnosis. Real progress, real lives changed, real hope for patients everywhere. #CancerSurvivor #HopeInScience #TCSC
www.curetoday.com/view/cancer-...
0
0
1
0
By targeting how tumour cells repair #DNA, this approach could help extend the life of treatments patients are already taking, instead of constantly moving to harsher options. #Oncology #TargetedTherapy #TCSC
0
0
0
0
Researchers have discovered that an existing drug can resensitise some ovarian cancers to PARP inhibitors, offering new hope when resistance sets in. Recycling old medicines in very clever ways. #OvarianCancer #CancerResearch #TCSC
scitechdaily.com/researchers-...
1
0
1
0
He stresses that older adults and those with comorbidities should not be written off, as newer therapies can deliver meaningful remissions with far less toxicity than in the past. #Hematology #Oncology #TCSC
1
0
0
0
In an in‑depth interview, Dr Richard Stone explains how AML care is shifting from “seven‑and‑three” chemo for everyone to precision combinations of targeted drugs, lower‑intensity regimens and transplant where needed. #AML #Leukemia #TCSC
www.targetedonc.com/view/targete...
1
0
1
0
The treatment offers longer survival for some patients and can be combined with chemo, giving hope where options had barely changed since the 1990s. #CancerNews #Oncology #TCSC
1
0
0
0
For the first time in more than 20 years, people with advanced head and neck cancer in England have a newly approved systemic option, after NICE backed an immunotherapy for routine NHS use. #HeadAndNeckCancer #Immunotherapy #TCSC
pharmaceutical-journal.com/article/news...
1
0
1
0
By testing surgery plus systemic therapy and modern imaging together, the study aims to find out which patients truly benefit from aggressive treatment and who can be spared extra toxicity. #Oncology #CancerResearch #TCSC
1
0
0
0
Yale has launched an innovative trial for metastatic bladder cancer that brings surgeons, medical #oncologists and radiation specialists into one team, rather than treating each step in a silo. #BladderCancer #ClinicalTrials #TCSC
medicine.yale.edu/news-article...
1
0
1
0
They highlight MRD‑driven strategies and powerful quadruple drug combinations that are deepening responses and pushing the field closer to the long‑term goal of curing myeloma. #Hematology #Oncology #TCSC
1
0
1
0
Researchers at Sylvester Myeloma Institute report rapid growth in myeloma clinical trials, precision medicine and new drug development, with 29 open studies and more on the way. #Myeloma #CancerResearch #TCSC
news.med.miami.edu/sylvester-my...
2
0
1
0